Navidea Biopharmaceuticals, Inc.(NYSE Amex Equities : NAVB)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| PFE | Pfizer Inc. | 0.48% | 53.97 | 0.9% | $1408.01m | |
| JNJ | Johnson & Johnson | -0.05% | 179.54 | 0.7% | $1296.44m | |
| BMY | Bristol-Myers Squibb Co. | 0.45% | 77.59 | 1.0% | $1212.16m | |
| MRK | Merck & Co., Inc. | -1.53% | 92.32 | 0.7% | $1167.02m | |
| ABBV | AbbVie, Inc. | -0.92% | 150.56 | 1.9% | $1100.30m | |
| LLY | Eli Lilly & Co. | 2.11% | 313.48 | 1.1% | $967.28m | |
| BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | -0.29% | 142.98 | 0.0% | $491.89m | |
| AZN | AstraZeneca Plc | -0.17% | 66.70 | 1.0% | $491.50m | |
| NVS | Novartis AG | 0.01% | 91.26 | 0.2% | $259.85m | |
| GSK | GlaxoSmithKline Plc | -1.23% | 44.42 | 0.2% | $257.59m | |
| VERU | Veru, Inc. | 2.18% | 12.64 | 0.0% | $253.71m | |
| HZNP | Horizon Therapeutics Plc | 2.45% | 90.59 | 5.4% | $196.03m | |
| SGEN | Seagen Inc. | 1.46% | 138.46 | 5.7% | $185.67m | |
| NVO | Novo Nordisk A/S | 1.30% | 106.62 | 0.1% | $182.89m | |
| VTRS | Viatris, Inc. | 1.44% | 12.01 | 0.0% | $165.27m |
Company Profile
Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutic. It operates through the following segments: Diagnostics, Therapeutics, and Corporate. The company was founded in 1983 and is headquartered in Dublin, OH.